American Airlines has become the latest airline to approve use of pharmaceutical cold chain solutions specialist Envirotainer’s Releye RLP and RAP containers.

The US carrier is looking to meet increasing demand to deliver life-saving medicines that need to be temperature-controlled in transit.

It said it will be “able to better support sensitive shipments in a highly regulated market while providing pharma shippers with secure and sustainable cold chain solutions”.

Eric Mathieu, head of customer experience for American Airlines Cargo, said: “We are thrilled to offer our customers another option for moving temperature-sensitive freight with us.

“The Releye RLP and RAP containers are reliably designed for transporting critical Life Sciences and Pharmaceutical shipments, making it a perfect addition to our current cold-chain network.”

Don Harrison, interim CSO at Envirotainer, added: “The addition of American Airlines to the growing family of carriers of our Releye containers is a significant milestone.

“American Airlines can now provide its customers with the latest fully connected solution to ensure the safety and quality of air freight pharmaceutical products throughout the supply chain.”

Envirotainer’s Releye range helps airlines and shippers to meet the strictest standards in pharmaceutical air freight.

The advanced containers were created with a focus on control, monitoring, autonomy, and reliability to minimise the likelihood of valuable product loss that could negatively impact patients’ health outcomes.